Cargando…

Differing time-orders of inflammation decrease between ACPA subsets in RA patients suggest differences in underlying inflammatory pathways

OBJECTIVES: Advanced imaging modalities have shown that not only joints but also bones and tendon sheaths can be inflamed at diagnosis of RA. We aimed to better understand the time-order in which the inflamed tissues respond to DMARD treatment. Also, because ACPA status may reflect a different patho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matthijssen, Xanthe M E, Niemantsverdriet, Ellis, Le Cessie, Saskia, van der Helm-van Mil, Annette H M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213431/ https://www.ncbi.nlm.nih.gov/pubmed/33164106 http://dx.doi.org/10.1093/rheumatology/keaa658

Ejemplares similares

ACPA-negative and ACPA-positive RA patients achieving disease resolution demonstrate distinct patterns of MRI-detected joint-inflammation
por: Verstappen, Marloes, et al.
Publicado: (2022)

A search to the target tissue in which RA-specific inflammation starts: a detailed MRI study to improve identification of RA-specific features in the phase of clinically suspect arthralgia
por: Matthijssen, Xanthe M. E., et al.
Publicado: (2019)

Enhanced treatment strategies and distinct disease outcomes among autoantibody-positive and -negative rheumatoid arthritis patients over 25 years: A longitudinal cohort study in the Netherlands
por: Matthijssen, Xanthe M. E., et al.
Publicado: (2020)

The value of the squeeze test for detection of subclinical synovitis in patients with arthralgia suspicious for progression to RA
por: Wouters, Fenne, et al.
Publicado: (2020)

Response to: “Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation” by Masi and Fleischmann
por: Boeters, Debbie M., et al.
Publicado: (2020)

Correction to: Response to: “Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation” by Masi and Fleischmann
por: Boeters, Debbie M., et al.
Publicado: (2020)

Intermetatarsal Bursitis, a Novel Feature of Juxtaarticular Inflammation in Early Rheumatoid Arthritis Related to Clinical Signs: Results of a Longitudinal Magnetic Resonance Imaging Study
por: van Dijk, Bastiaan T., et al.
Publicado: (2022)

Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis
por: Verstappen, M., et al.
Publicado: (2020)

MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF
por: Boeters, Debbie M., et al.
Publicado: (2016)

ACPA-negative RA consists of subgroups: patients with high likelihood of achieving sustained DMARD-free remission can be identified by serological markers at disease presentation
por: Boeters, Debbie M., et al.
Publicado: (2019)

ACPA-Negative RA Consists of Two Genetically Distinct Subsets Based on RF Positivity in Japanese
por: Terao, Chikashi, et al.
Publicado: (2012)

The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical
por: Boeters, Debbie M., et al.
Publicado: (2017)

Undifferentiated arthritis: a changing population who did not benefit from enhanced disease-modifying anti-rheumatic drug strategies—results from a 25 year longitudinal inception cohort
por: Verstappen, Marloes, et al.
Publicado: (2021)

Immunoprofiling of early, untreated rheumatoid arthritis using mass cytometry reveals an activated basophil subset inversely linked to ACPA status
por: Koppejan, H., et al.
Publicado: (2021)

Value of imaging detected joint inflammation in explaining fatigue in RA at diagnosis and during the disease course: a large MRI study
por: Matthijssen, X M E, et al.
Publicado: (2021)

Hand function is already reduced before RA development and reflects subclinical tenosynovitis
por: Krijbolder, Doortje Isabelle, et al.
Publicado: (2023)

Ways forward to identify new ACPA targets in RA
por: Ytterberg, A Jimmy, et al.
Publicado: (2012)

Inflammation functions as a key mediator in the link between ACPA and erosion development: an association study in Clinically Suspect Arthralgia
por: ten Brinck, R. M., et al.
Publicado: (2018)

The Role of Genetics in Clinically Suspect Arthralgia and Rheumatoid Arthritis Development: A Large Cross‐Sectional Study
por: Maurits, Marc P., et al.
Publicado: (2022)

An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting
por: van Heemst, Jurgen, et al.
Publicado: (2015)

Walking Disabilities in Association With Tenosynovitis at the Metatarsophalangeal Joints: A Longitudinal Magnetic Resonance Imaging Study in Early Arthritis
por: Dakkak, Yousra J., et al.
Publicado: (2022)

The earlier, the better or the worse? Towards accurate management of patients with arthralgia at risk for RA
por: van der Helm-van Mil, Annette, et al.
Publicado: (2020)

The fine specificity of IgM anti-citrullinated protein antibodies (ACPA) is different from that of IgG ACPA
por: Suwannalai, Parawee, et al.
Publicado: (2011)

MRI-detected synovitis of the small joints predicts rheumatoid arthritis development in large joint undifferentiated inflammatory arthritis
por: Sidhu, Navkiran, et al.
Publicado: (2021)

Increased frequency of intermetatarsal and submetatarsal bursitis in early rheumatoid arthritis: a large case-controlled MRI study
por: Dakkak, Yousra J., et al.
Publicado: (2020)

Grip strength reduction in clinically suspect arthralgia: natural trajectories and improvement after treatment
por: Krijbolder, Doortje I, et al.
Publicado: (2023)

A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis
por: Padyukov, Leonid, et al.
Publicado: (2010)

Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets
por: van der Helm-van Mil, Annette HM, et al.
Publicado: (2008)

ACPA fine-specificity profiles in early rheumatoid arthritis patients do not correlate with clinical features at baseline or with disease progression
por: van Beers, Joyce JBC, et al.
Publicado: (2013)

Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patients
por: Xu, Minjie, et al.
Publicado: (2023)

Joint involvement in RA starts predominantly in the hands: functional, clinical and imaging studies in clinically suspect arthralgia and during progression to RA
por: Khidir, Sarah J H, et al.
Publicado: (2023)

The value of inquiring about functional impairments for early identification of inflammatory arthritis: a large cross-sectional derivation and validation study from the Netherlands
por: van Dijk, Bastiaan T, et al.
Publicado: (2020)

Anti-citrullinated peptide/protein antibody (ACPA)-negative RA shares a large proportion of susceptibility loci with ACPA-positive RA: a meta-analysis of genome-wide association study in a Japanese population
por: Terao, Chikashi, et al.
Publicado: (2015)

The relation between physical joint examination and MRI-depicted inflammation of metatarsophalangeal joints in early arthritis
por: Dakkak, Yousra J., et al.
Publicado: (2020)

Improving the feasibility of MRI in clinically suspect arthralgia for prediction of rheumatoid arthritis by omitting scanning of the feet
por: Boer, Aleid C, et al.
Publicado: (2020)

Unraveling heterogeneity within ACPA-negative rheumatoid arthritis: the subgroup of patients with a strong clinical and serological response to initiation of DMARD treatment favor disease resolution
por: Verstappen, M., et al.
Publicado: (2022)

Work participation is reduced during the development of RA, months before clinical arthritis manifests
por: Rogier, Cleo, et al.
Publicado: (2021)

Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity
por: Cunningham, Kevin Y., et al.
Publicado: (2023)

Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis
por: Ohmura, Koichiro, et al.
Publicado: (2010)

Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?
por: De Rooy, Diederik PC, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_sgkgn2c8sm62mmu11tsdbv34ep